ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 129 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $671,000 | -59.5% | 209,882 | -61.8% | 0.00% | -100.0% |
| Q2 2018 | $1,658,000 | -48.3% | 548,865 | -33.0% | 0.00% | 0.0% |
| Q1 2018 | $3,210,000 | -5.3% | 818,865 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,391,000 | -32.6% | 818,865 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $5,028,000 | -1.3% | 818,865 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $5,093,000 | -22.6% | 818,865 | -21.2% | 0.00% | -33.3% |
| Q1 2017 | $6,584,000 | +18.5% | 1,038,528 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $5,556,000 | -0.5% | 1,038,528 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $5,584,000 | +39.4% | 1,038,528 | +42.3% | 0.00% | +50.0% |
| Q2 2016 | $4,007,000 | -26.0% | 729,887 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $5,416,000 | -10.7% | 729,887 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $6,065,000 | +19.9% | 729,887 | +30.1% | 0.00% | 0.0% |
| Q3 2015 | $5,057,000 | – | 561,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,642,959 | $25,186,000 | 3.76% |
| MSD Partners, L.P. | 15,151,516 | $26,061,000 | 2.11% |
| MSD Partners, L.P. | 7,575,758 | $13,030,000 | 1.05% |
| MAGNOLIA CAPITAL ADVISORS LLC | 418,569 | $720,000 | 0.61% |
| STEEL GROVE CAPITAL ADVISORS, LLC | 1,080,000 | $1,858,000 | 0.33% |
| EAM Investors, LLC | 454,625 | $782,000 | 0.17% |
| Allred Capital Management, LLC | 158,000 | $271,000 | 0.17% |
| Boxer Capital, LLC | 1,500,000 | $2,580,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 608,037 | $1,046,000 | 0.14% |
| CHIRON CAPITAL MANAGEMENT, LLC | 116,860 | $201,000 | 0.14% |